Efficacy of Acellular Pertussis Vaccine Over Time
Undervaccinated and especially unvaccinated children were at greater risk for pertussis.
All articles by Bradley van Paridon
Pathogens, Drug Resistance in People With Diabetes, Acute Cerebral Infarction and Pulmonary Infection
Multidrug-resistant gram-negative bacilli were the pathogens commonly found in patients with acute cerebral infarction complicated by diabetes mellitus and nosocomial pulmonary infection.
Comparative Accuracy of Tests to Detect Pulmonary Tuberculosis
In a review update, XpertMTB/RIF was found to be sensitive and specific for diagnosing pulmonary TB and rifampicin resistance which is consistent with the last review completed in 2014.
Molecular Methods Show PCV Vaccine May Reduce Colony Density, Not Acquisition
The PCV-13 demonstrated an association with the detection of low-density colonization and resulted in vaccine efficacy against colonization acquisition.
Hospital Staff Mask Protocols Reduce Nosocomial Influenza Transmission
The “Masks Save Lives” campaign is highly effective in preventing nosocomial influenza infection in clinical settings.
Accuracy of Rapid MALDI-TOF Bacterial Identification for Bloodstream Infections
The MALDI-TOF assay demonstrated accuracy in the rapid identification of the most commonly isolated strains of bacterial colonies isolated from positive blood cultures.
Histoplasmosis-Related Healthcare Use, Diagnosis, and Treatment in the US
Histoplasmosis is associated with a wide spectrum of illness and a substantial burden for some patients.
Ceftolozane/Tazobactam Noninferior to Meropenem for Nosocomial Pneumonia
A combination dose of ceftolozane/tazobactam is noninferior to meropenem for treating nosocomial pneumonia.
First Clinical Development Candidate of Cidara’s Influenza Program Announced
Data supporting the selection of the antiviral conjugate CB-012 as Cidara Therapeutics Incorporated’s first clinical development candidate from the company’s influenza program.
Rifapentine Plus Isoniazid Noninferior to Isoniazid in HIV-Related TB
For prevention of TB in people with HIV, a single month regimen of rifapentine plus isoniazid was noninferior to 9 months of isoniazid alone.
Next post in Tuberculosis
